Combo SARS-CoV-2 / Influenza A and B / RSV
The SARS-CoV-2 + FLU A/B + RSV Combo Test Kit is an in vitro immunochromographic test
for the qualitative detection of SARS-CoV-2, influenza A / B and RSV antigens in nasal
or nasopharyngeal swab samples.
This test is intended for use as an aid in the differential diagnosis of SARS-CoV-2, influenza A / B and RSV viral infections in humans in conjunction with clinical and epidemiological risk factors.
1 smear = 4 results
The product is designed for use by professionals.
Properties
Detection of influenza A, influenza B, RSV virus, COVID-19.
Test result already after 15 minutes.
Sample taken from the nose or nasopharynx.
High quality product.
Simple to use.
Intended for use by professionals.
SARS-CoV-2 nasal swab: specificity 99.57%, sensitivity 98.59%.
SARS-CoV-2 nasopharyngeal swab: specificity 99.52%, sensitivity 98.94%.
Influenza A nasal swab: specificity 99.57%, sensitivity 98.34%.
Influenza A nasopharyngeal swab: specificity 99.52%, sensitivity 98.90%.
Influenza B nasal swab: specificity 99.57%, sensitivity 98.19%.
Influenza B nasopharyngeal swab: specificity 99.52%, sensitivity 98.80%.
RSV nasal swab: specificity 99.99%, sensitivity 99.72%.
RSV nasopharyngeal swab: specificity 99.89%, sensitivity 99.27%.
Detection of SARS-CoV-2 test specifications:
Results for nasal swab:
Results for nasopharyngeal swab:
Influenza A+B detection test specifications:
Results for nasal swab:
Results for nasopharyngeal swab:
Detection of RVS test specitication:
Results for nasal swab:
Results for nasopharyngeal swab:
Application
- Test for the qualitative, differential detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV).
- Accurate diagnosis makes it possible to implement the most effective forms of therapy, thereby reducing the time needed to cure the patient.
- The test is designed for screening and serves as an aid in the diagnosis of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV).
